ETAGX (ETAGX) Stock Price & Analysis
ETAGX (ETAGX) rose 0.20% to USD 61.61 as of September 9, 2026 at 03:46 UTC, according to Nexqual real-time market data.
ETAGX last closed at USD 61.49; the session ranged USD 61.61–61.61 on volume of 0 shares. Market capitalization is —, with a 52-week range of USD 48.37–66.38 (NAS). Source: Nexqual, September 9, 2026 at 03:46 UTC.
Key Statistics (as of September 9, 2026 at 03:46 UTC)
| Price | USD 61.61 |
|---|---|
| Change | ▲ 0.20% (up) |
| Previous Close | USD 61.49 |
| Open | USD 61.61 |
| Day Range | USD 61.61 – 61.61 |
| 52-Week Range | USD 48.37 – 66.38 |
| Volume | 0 shares |
| Market Cap | — |
| Exchange | NAS |
Technical Analysis (ETAGX)
Nexqual's technical model rates ETAGX "STRONG SELL" based on 0 bullish and 5 bearish signals across 127 daily candles, as of September 9, 2026 at 03:46 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 45.52 (neutral) |
| vs SMA50 | Below (USD 62.8) |
| MACD | -0.37 (negative) |
Financial Health Score (ETAGX)
Nexqual rates ETAGX's overall financial health "Mixed" across five dimensions, as of September 9, 2026 at 03:46 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ETAHX | Eventide Healthcare & Life Scie | USD 57.95 | ▲ 0.33% |
| ETILX | Eventide Gilead Fund Institutio | USD 64.94 | ▲ 0.85% |
| ETGLX | Eventide Gilead Fund | USD 62.2 | ▲ 0.86% |
| ETCGX | Eventide Gilead Fund Class C | USD 51.7 | ▲ 0.84% |
| ETCHX | Eventide Healthcare & Life Scie | USD 51.96 | ▲ 0.33% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 9, 2026 at 03:46 UTC. This page is informational and not investment advice.